These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6955550)

  • 1. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
    Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F; Genovesi EV; Collins JJ
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
    Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
    Genovesi EV; Livnat D; Collins JJ
    J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM; Brown JP; Hellström KE; Hellström I
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY; Rosenberg SA
    Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.
    Britt WJ; Chesebro B
    J Immunol; 1983 May; 130(5):2363-7. PubMed ID: 6833759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of natural killer cell activity by Friend murine leukemia virus.
    Moody DJ; Specter S; Bendinelli M; Friedman H
    J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectivity of Friend murine leukemia virus for hamster cells.
    Ishimoto A
    J Natl Cancer Inst; 1985 Apr; 74(4):905-8. PubMed ID: 3857383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas.
    Grant JP; Bigner DD; Fischinger PJ; Bolognesi DP
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):5037-41. PubMed ID: 4373739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
    Sugahara D; Tsuji-Kawahara S; Miyazawa M
    J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
    Genovesi EV; Collins JJ
    J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.